Chinese stocks slump on first trading day of 2025
Chinese stocks suffered in the new year from their worst first day of trading since 2016, despite a state stimulus package

Chinese shares rose 15% in 2024 for their first annual gain since 2020, says Bloomberg News. But “sentiment remains fragile”, with the CSI 300 index enduring its worst first trading day of a new year since 2016. Most of last year’s equity gains came following a “late September stimulus blitz”. Yet since then trading has been “range-bound” as investors wait for official announcements of more economic stimulus.
Why are Chinese stocks tumbling?
Stock markets have been cheered by a $1.4 trillion package of support for indebted local governments and promises of easier monetary policy, but bonds are telling “a bleaker story”, says Jacky Wong in The Wall Street Journal. Local bond yields have been falling – suggesting investors anticipate low inflation and weaker growth.
China’s 30-year bond yield traded at more than 4% in 2018, but recently fell below 2%, less than the equivalent in deflation-prone Japan. Japan learnt the hard way that “it takes strong, overwhelming stimulus to exit a deflationary spiral”. Markets aren’t convinced help on that scale is in the pipeline in China.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
State stimulus certainly moves markets in the short term, says Nicholas Spiro in the South China Morning Post. This autumn’s announcements saw the CSI 300 rocket 32.5% between September 23 and October 8. Yet despite continued measures aimed at stabilising the property market and helping consumption, trading has turned “volatile” in recent months. “The size... of the stimulus package” may be “less consequential than previously assumed”.
Economists are also concerned about deeper “structural challenges, including heavily indebted local governments, an ageing population” and “excessive dependence on exports” says Reshma Kapadia in Barron’s. But stimulus is part of the picture and we may be in line for more – especially if Beijing is pressed into extra spending this year to offset Trump’s planned “volley of increased tariffs on Chinese imports”.
The bulls haven’t been routed. Goldman Sachs notes that government spending “has historically had a stronger impact on Chinese equity returns than monetary easing”, says Cao Li in the South China Morning Post. Goldman argues the stimulus policy puts a “floor” on the Chinese equity market. Moreover, says Hudson Lockett for Breakingviews, firms are “undervalued” and boast “higher cash flow and profitability relative to global peers”.
Yet sentiment is “precarious”. Tech giant Tencent’s shares sold off 7% in Hong Kong on 7 December after it was added to a US list of “Chinese military companies”. The classification carries “no material consequences” but shows that “perception” is important, too. Fund managers who bought into “last year’s rally” may start to conclude that “buying into the bull case is more trouble than it’s worth”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
HMRC confirms crypto ETN ISA rules
With crypto ETNs now technically available for UK retail investors, HMRC has confirmed they can be held in an ISA – but there’s a complication
-
Pensioners targeted in fine wine scams – the tactics to watch for
Wine has emerged as the latest lure in investment fraud, with pensioners being specifically targeted by scammers
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?